Kang Stem Biotech receives final clinical report for 'Oscar' trial, says 'consistency of key results confirmed'
Predicted impact: Low
Final clinical trial report receipt; results described only as consistent, with no size given.
217730 · KOSDAQ · ₩217730 · 강스템바이오텍
Predicted impact: Low
Final clinical trial report receipt; results described only as consistent, with no size given.
Also known as: Kangstem Biotech / 강스템바이오텍 / 217730 / KRX:217730
Source: KRX statistical information